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Abstract
The density and duration of pneumococcal carriage are considered to affect the likelihood of transmission and invasive disease. Because of
its importance in both spreading and causing disease, carriage has been suggested as an endpoint in future vaccine studies. Culture is the
current gold standard for detection, but may not be sensitive enough to detect changes at low density. Healthy adult volunteers received an
intranasal inoculation of Streptococcus pneumoniae serotype 6B. Pneumococcal density in nasal washes collected at six time-points
post-inoculation was determined by culture and quantitative PCR (qPCR). Natural pneumococcal carriers detected at initial screening were
followed in parallel. In 331 nasal washes from 79 volunteers, the sensitivity and specificity of pneumococcal detection by qPCR, as compared
with culture, were 92.3% and 75.9%. The estimation of pneumococcal density by culture and qPCR was highly correlated (rs = 0.73,
p <0.0001), although qPCR had a lower detection limit. Pneumococcal density fluctuated within a carriage episode, and occasionally fell
below the detection limit of both methods. The duration of carriage episodes was underestimated when only one method was used. Similar
fluctuations in density were observed in natural carriers. Pneumococcal carriage is a dynamic event. Culture and qPCR are complementary
for surveying the density and duration of pneumococcal carriage episodes.
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Introduction
Colonization of the nasopharynx by Streptococcus pneumoniae
(pneumococcus) is common, with carriage rates in children
aged <5 years of 40–90%, and stabilizing at approximately 10%
in adults [1–3]. Understanding colonization is important, as it is
implicated in both person-to-person transmission and spread
within the body, potentially leading to meningitis, bacteraemia,
or pneumonia. To what extent the density and duration of
pneumococcal carriage affect the risk of transmission and
invasive disease is being increasingly scrutinized [4,5].
The WHO currently recommends nasopharyngeal swabs to
detect pneumococcal carriage in children [6]. In adults, the
best sampling method is less clear. We have previously
suggested that nasal wash (NW) is better than nasopharyngeal
swabs for detecting potential nasopharyngeal pathogens, and it
provides the opportunity to examine the immune response
[7]. Recently, trans-oral swabs have been suggested to be
superior to trans-nasal swabs for detecting pneumococcal
carriage in adults [8]. Detection of live pneumococci by culture
is the current gold standard [6]. However, culture and
molecular methods can be combined to increase carriage
detection, including detection of multiple serotypes [9]. This
can be achieved by including an enrichment step prior to
culture and molecular analysis, or by combining data from both
culture and molecular methods, which allows density to be
determined for each method separately [10].
ª2014 The Authors
Clinical Microbiology and Infection ª2014 European Society of Clinical Microbiology and Infectious Diseases
ORIGINAL ARTICLE EPIDEMIOLOGY
Open access under CC BY-NC-ND license.
Understanding carriage is also important in the context of
vaccination. Pneumococcal conjugate vaccines have resulted
in a decrease in the rates of invasive disease and carriage of
vaccine-serotype pneumococci [11,12]. However, whereas
carriage of vaccine-type pneumococci has declined, carriage
of non-vaccine-type pneumococci has increased [13,14]. The
long-term impact of vaccination can be measured by using
carriage data, which can provide an estimate of post-vaccine
changes in invasive disease incidence [15]. Colonization has
been suggested as an endpoint because it is relatively easy
to measure and is more common than disease, and
therefore requires a much smaller sample size in a vaccine
trial [16–18]. However, to identify small changes in the
density or duration of colonization, sensitive methods to
accurately detect these changes will be important in
estimating vaccine effects.
In this study, we used an experimental human pneumo-
coccal carriage model to longitudinally follow carriage
episodes, and compared detection of carriage by culture
and quantitative PCR (qPCR). We focused on carriage
density and duration in experimental carriers, but also
compared both parameters in natural carriers, who were
followed in parallel.
Materials and Methods
Recruitment and ethics
Healthy volunteers were enrolled, with informed consent,
in an experimental human pneumococcal carriage trial [19]. All
participants were non-smoking adults aged 18–60 years who
had no close contact with at-risk individuals, including young
children and the elderly. Ethical approval was obtained from
the National Health Service Research Ethics Committee
(11/NW/0592), and the study was sponsored by the Royal
Liverpool and Broadgreen University Hospitals Trust.
Experimental nasopharyngeal challenge
Pneumococcal stock preparation and inoculation were per-
formed as previously described [19]. Briefly, a serotype 6B
clinical isolate (BHN418) [20] was grown to an optical density
at 600 nm of 0.2–0.3 in Vegitone broth (Oxoid, Basingstoke,
UK), and stored in 1-mL aliquots containing 10% glycerol at
80°C. Serotype confirmation was performed by latex
agglutination (Statens Serum Institute, Copenhagen, Denmark),
and bacterial stock purity and penicillin sensitivity were
confirmed by an independent reference laboratory (Public
Health England, London, UK). Eighty-four volunteers received
a pneumococcal inoculation of between 10 000 and
320 000 CFUs per naris.
Quantification of pneumococci by culture
NW samples were collected before inoculation and at days 2,
7, 14, 21, 28 and 35 post-inoculation, and were processed as
previously described [19]. If pneumococci were detected at
the pre-inoculation screening, the volunteer was not chal-
lenged, but returned for a NW at the same time-points as
those in whom pneumococci were detected. Plates were
inspected after 24 h of incubation at 37°C in 5% CO2.
a-haemolytic, draughtsman-like colonies were Gram-stained
and subcultured for optochin sensitivity and bile solubility.
Pneumococcal serotype was confirmed by latex agglutination.
Carriage density by culture was determined as previously
described, with minor modifications [19]. Briefly, the NW
bacterial pellet was resuspended in 100 lL of skimmed-milk
tryptone glucose glycerol (STGG) medium, and the total
volume of the suspension was determined. The suspension was
then serially diluted on blood agar. On the next day, CFUs/lL
were determined, and multiplied by the suspension volume.
This value was then divided by the amount of NW returned by
the volunteer to obtain CFUs/mL of NW.
Bacterial DNA extraction
Directly after NW collection, 2 mL was added to 4 mL of
RNAprotect Bacteria Reagent (Qiagen, Manchester, UK).
After 5 min of incubation at room temperature, the sample
was transferred to the laboratory on ice and stored at 80°C.
The thawed suspension was pelleted in a 2-mL tube by three
centrifugation steps at 19 090 g for 20 min at 4°C. The pellet
was resuspended in 0.3 mL of lysis buffer with protease
(Agowa Mag mini DNA extraction kit; LGC Genomics, Berlin,
Germany), 50 mg of sterilized zirconia/silica beads (diameter
of 0.1 mm; Biospec Products, Bartlesville, OK, USA), and
0.3 mL of phenol (Phenol BioUltra; Sigma-Aldrich, Zwijn-
drecht, The Netherlands). The sample was mechanically
disrupted by bead beating in a TissueLyser LT (Qiagen, Venlo,
The Netherlands) twice at 50 Hz for 2 min. After centrifuga-
tion, the aqueous phase was transferred to a sterile 1.5-mL
tube. Binding buffer was added at twice the volume of the
aqueous phase plus 10 lL of magnetic beads, after which the
sample was incubated in a mixing machine for 30 min at room
temperature. The magnetic beads were washed with 200 lL of
both wash buffer 1 and wash buffer 2, and eluted with 63 lL
of elution buffer, according to the manufacturer’s instructions.
Quantification of pneumococcal DNA by qPCR
Carriage density by qPCR was determined by partial amplifi-
cation of the lytA gene. The primer and probe sequences were
as follows: forward primer, 50-ACGCAATCTAGCAG
ATGAAGCA-30; reverse primer, 50-TCGTGCGTTTTA
ATTCCAGCT-30; probe, 50-(FAM)-GCCGAAAACGCTTG
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ATACAGGGAG-(BHQ1)-30 [21]. The 20-lL PCR mix
consisted of 1 9 TaqMan Universal PCR Master Mix (Life
Technologies, Bleiswijk, TheNetherlands), 0.1 lM each primer,
0.1 lM probe, and 1 lL of the extracted DNA. Thermal cycling
was performed in an ABI 7500 Fast Real-Time PCR System (Life
Technologies) under the following cycling conditions: 2 min at
50°C, 10 min at 95°C, and 40 cycles of 15 s at 95°C and 1 min at
60°C. A standard curve of a ten-fold dilution series of genomic
DNA extracted from S. pneumoniae (TIGR4, ATCC BAA-334)
was used. The genomic DNA was extracted with the Qiagen
Genomic-tip 20/G Kit (Qiagen), and quantified with a spectro-
photometer (Nanodrop ND-1000; Thermo Fisher Scientific,
Landsmeer, The Netherlands). The conversion from weight of
pneumococcal DNA to number of S. pneumoniae DNA copies
was based on the weight of one genome copy of TIGR4
calculated as the genome length in base pairs times the weight of
a DNA base pair (650 Da). The lower limit of detection was set
at 40 cycles. A NW was considered to be positive if both
duplicates yielded a qPCR signal below 40 cycles.
Statistical analysis
Differences in proportions of samples positive for carriage
were statistically tested with a chi-square test (Fisher’s exact
test if there were more than ten cases in a cell). Quantitative
data were compared by the use of Spearman’s rank correlation
coefficient. Graphical and statistical analyses were performed
with GraphPad prism version 5.0 (GraphPad Software, La Jolla,
CA, USA). All p-values were two-tailed, and a p-value of ≤0.05
was considered to be significant.
Results
Comparison of culture and qPCR for the detection of
pneumococci
Three hundred and thirty-one NW samples collected from
79 volunteers were tested by microbiological culture and
qPCR for the presence of S. pneumoniae. The proportion of
samples positive for carriage by qPCR was significantly higher
than the proportion of samples positive for carriage by
culture (42.6% vs. 27.5%, p <0.0001) (Table 1). The sensitiv-
ity of detection by qPCR was 92.3% (84/91) as compared
with culture, and the specificity was 75.9% (183/241). In 2.1%
of samples, pneumococci were detected by culture but not
qPCR, and in 17.2% of samples pneumococci were detected
only by qPCR.
The proportion of carriage-positive volunteers was also
determined over time (Fig. 1). Across all time-points, the
number of volunteers positive for carriage by qPCR was higher
than the number positive for carriage by culture, but this was
only significant at 2 days post-challenge (p 0.009).
Correlation of density detected by culture and by qPCR
The pneumococcal density correlation between culture and
qPCR was determined for 147 samples. One sample was
excluded from analysis because the number of colonies on the
culture plate was too high for accurate determination of CFUs/
mL. Quantification of pneumococci by culture and by qPCR
were positively correlated (rs = 0.73, p <0.0001) (Fig. 2). The
detection limit for qPCR was the number of copies still
detectable after 40 cycles, or 101 DNA copies/mL. The limit
of detection for culture was set at the lowest density detected,
or 0.2 CFUs/mL.
When pneumococcal detection by culture was stratified by
qPCR density, the difference between the two methods
became apparent. If the qPCR density was >103 copies/mL,
94.8% (55/58) of samples were both culture-positive and
qPCR-positive (Table 2). However, at densities ranging
between 101 and 102, only 34.55% (29/84) of qPCR-positive
samples were also positive by culture (p <0.0001). Below the
qPCR limit of detection, 7.7% (7/91) of samples were still
positive by culture. In all but one of these samples, the culture
density was lower than 10 CFUs/mL.
Fluctuations in carriage density are accurately detected when
both culture and qPCR are used for detection
Culture and qPCR were used to examine pneumococcal
detection over time in four experimentally colonized and three
naturally colonized volunteers. The fluctuations in density
during a carriage episode were similar for both experimentally
and naturally colonized volunteers (Fig. 3). As shown in Fig. 3a,
volunteer 1 was culture-negative but qPCR-positive at two
consecutive time-points (days 7 and 14). In contrast, volun-
teer 2 was culture-positive but qPCR-negative on day 28. In
both cases, the carriage status varied according to the method.
This variation was also seen in natural carriers (Fig. 3c). Both
methods were beneficial for determining the length of a
carriage episode. Volunteers 3 and 4 (Fig. 3b) had at least two
samples positive by both culture and qPCR, but then at least
three consecutive samples negative by culture but positive by
qPCR. This pattern was also seen in natural carriers of
serotype 33 (Fig. 3c).
TABLE 1. Comparison of bacterial culture and quantitative
PCR (qPCR) for the detection of Streptococcus pneumoniae
Culture-
positive (%)
Culture-
negative (%) Total (%)
qPCR-positive (%) 84 (25.4) 57 (17.2) 141 (42.6)
qPCR-negative (%) 7 (2.1) 183 (55.3) 190 (57.4)
Total 91 (27.5) 241 (72.8) 331 (100)
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Discussion
Longitudinal NW samples from adults who were intranasally
challengedwith pneumococci were assessed for carriage density
by culture and qPCR. We detected a higher pneumococcal
carriage rate with qPCR than with culture but pneumococcal
densities measured with the two methods were positively
correlated. The culture positivity rate decreased in parallel with
the decrease in density measured by qPCR. Culture and qPCR
were complementary in assessing the number and length of
carriage episodes in both experimental and natural carriage.
The strength of this study is the determination of density by
both culture and qPCR during a controlled carriage episode.
We observed a high correlation between the two methods in
calculating density. Absolute numbers were 1–2 log10 lower by
culture, which is in line with observations previously reported
by Albrich et al. [4]. The difference may be attributable to the
inability of qPCR to distinguish between live and dead bacteria
—an important distinction in low-density samples. Lower
culture density may also be a result of the pneumococcal
tendency to grow in pairs and chains. More than one
pneumococcus can form a single colony, but qPCR will detect
each individual bacterium.
Detection of pneumococcal carriage by culture is the gold
standard [6] and Isolation of the pneumococcus allows further
tests to be performed to determine serotype and antibiotic
FIG. 1. Proportion of carriage-positive volunteers detected by bacterial culture or quantitative PCR (qPCR) over time. For detection by culture,
nasal wash samples were plated on blood agar with gentamicin. For qPCR detection, nasal wash was added to RNAprotect and frozen until DNA
extraction. A volunteer was considered to be positive by culture (white bar) if Gram-positive, a-haemolytic, optochin-sensitive colonies were
detected after 48 h. Serotype was confirmed by latex agglutination. The target gene for qPCR was lytA. Samples with a Ct value of <40 were
considered to be qPCR-positive (black bar). The number of samples analysed is indicated above each time-point. *Statistical significance (p ≤0.05)
FIG. 2. Correlation between bacterial culture and qPCR in quanti-
fying Streptococcus pneumoniae in nasal wash (NW) samples. Quanti-
fication of pneumococci by culture and by qPCR are positively
correlated. The Spearman rank correlation coefficient for samples
positive by both culture and qPCR is 0.73. Dotted lines represent
lower limits of detection. A p-value of ≤0.05 was considered to be
significant.
TABLE 2. Detection of pneumococci in nasal wash by bac-
terial culture and quantitative PCR (qPCR), categorized
according to qPCR density
Density by qPCR
(copies/mL)
No. culture-positive/no.
qPCR-positive (%)
<10 7/0
101 6/37 (16.2)
102 23/47 (48.9)
103 30/32 (93.8)
104 14/14 (100)
105 11/12 (91.7)
Total 91/142 (64.1)
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sensitivity. Culture is also more feasible in resource-limited
settings. Non-culture methods are increasingly being used to
detect pneumococci. Several studies have focused on gene
targets by using qPCR, with lytA being the most widely used
gene, and have shown that a qPCR-based method is more
sensitive than culture [21,22]. There have been concerns over
the specificity of lytA and the possibility that it may not
discriminate between S. pneumoniae and viridans streptococci;
however, our specificity (75.9%) was similar to that reported
by Carvalho et al. [21] in cerebrospinal fluid samples (70%). To
increase sensitivity, some studies have included an enrichment
step, but this cannot be used when quantification is an
endpoint [8,10].
A lower detection rate by culture than by qPCR could be
explained by the potential for subclinical—or low–density—
carriage. Turner et al. [9] showed that detection of multiple
serotypes in nasopharyngeal samples is significantly
underestimated when using standard WHO protocol, which
is able to detect a predominant serotype but is not efficient
at detecting low-abundance serotypes. This is linked with
(a)
(b)
(c)
FIG. 3. Culture and quantitative PCR
(qPCR) are complementary for following
a carriage episode. (a, b) At low density,
carriage results can vary by method, which
can impact on (a) the number of carriage
episodes and (b) the duration of carriage
episodes. (c) Natural carriage episodes
mimic the variation seen in experimental
carriage. Filled shapes: carriage-positive by
culture. Open shapes: carriage-negative by
culture. Dotted lines represent lower
limits of detection. NW, nasal wash.
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serotype replacement, where it is unclear whether the
increase in non-vaccine-type pneumococci is attributable to
the elimination of vaccine-type pneumococci, or whether the
replacement occurs because non-vaccine types are carried at
low density and are simply ‘unmasked’ when vaccine types
are inhibited or removed [11,13]. Low-density carriage could
explain the differences between culture and qPCR seen
here; at a density of <102, the low abundance is missed by
culture but picked up by qPCR.
It has been shown in children that, at a density of
<105 CFUs/mL, significantly fewer carriers are detected by
culture, not only for pneumococcus but also for Staphylococcus
aureus and Haemophilus influenzae [22]. However, as we have
shown here and discussed previously, we are able to detect
carriage by culture at <10 copies/mL, and suggest that, when a
fresh NW sample is used, culture and qPCR are equally
sensitive up to 102 CFUs/mL [23].
The parallel decreases in culture positivity rates and
pneumococcal densities measured by qPCR suggest that qPCR
is more suitable for detecting low levels of carriage. However,
qPCR is not informative regarding the viability of pneumococci
in the nasopharynx. As seen in Fig. 3b, continuous qPCR
detection when culture results are negative may represent
prolonged low-density carriage, living cells that are in a
culture-unfavourable metabolic state, or remaining pneumo-
coccal debris. Also, intermittent positive culture results could
be misconstrued as separate carriage episodes when they
actually represent a single carriage episode as supported by
qPCR detection (Fig. 3a). With application of both methods,
the chance of missing pneumococcal carriage may be reduced.
In our controlled environment, the most advantageous
approach for the longitudinal study of a carriage episode is
to use both methods.
Inconsistencies between culture and qPCR detection could
also be explained by decreasing success rates at the threshold
of detection. Culture densities were low (<10 CFUs/mL) in six
of seven qPCR-negative samples, and, in 54 of 57 culture-
negative samples, qPCR densities were <103 copies/mL. The
higher density inconsistencies could be attributable to exper-
imental error; culture-positive/qPCR-negative samples could
be the result of faulty DNA extraction or the exclusion of
qPCR signals of <10 copies/mL (>40 cycles). Four of the seven
exclusively culture-positive samples were analysed again with a
different lytA primer set, but remained negative for pneumo-
coccal DNA [24]. We chose a threshold of 40 cycles, which
was used in the development of the lytA qPCR assay. We
observed that the success rate of detection with the standard
curve was still 100% at 40 cycles, and that the standard curve
still followed a straight line at 40 cycles. In addition, almost all
samples detected between 35 and 40 cycles were positive in
both duplicates. These observations imply that the lower limit
of detection of our method had not yet been reached at 40
cycles. This cut-off is two cycles higher than that used in the
study with children, possibly explaining the differences in
detection limits between the two studies [21,22].
Our study surveyed adult pneumococcal carriage in con-
secutive NW samples. However, this sampling method is less
suited for those who are unable to actively participate in
sample collection (e.g. young children). Further studies will
need to determine whether our observations hold true for
different sampling methods and populations.
Carriage is a dynamic event, and we have shown that an
experimental human carriage model mimics a natural carriage
episode. The data from our study indicate that culture and
qPCR are highly complementary for studying pneumococcal
carriage episodes, especially when the carriage density is low.
This is important information for future vaccine studies in
which carriage density or duration may be an endpoint.
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